Role of the nuclear receptor coactivator AIB1/SRC-3 in angiogenesis and wound healing. 2012

Maram Al-Otaiby, and Elena Tassi, and Marcel O Schmidt, and Chris D Chien, and Tabari Baker, and Armando Ganoza Salas, and Jianming Xu, and Mary Furlong, and Richard Schlegel, and Anna T Riegel, and Anton Wellstein
Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC 20057, USA.

The nuclear receptor coactivator amplified in breast cancer 1 (AIB1/SRC-3) has a well-defined role in steroid and growth factor signaling in cancer and normal epithelial cells. Less is known about its function in stromal cells, although AIB1/SRC-3 is up-regulated in tumor stroma and may, thus, contribute to tumor angiogenesis. Herein, we show that AIB1/SRC-3 depletion from cultured endothelial cells reduces their proliferation and motility in response to growth factors and prevents the formation of intact monolayers with tight junctions and of endothelial tubes. In AIB1/SRC-3(+/-) and (-/-) mice, the angiogenic responses to subcutaneous Matrigel implants was reduced by two-thirds, and exogenously added fibroblast growth factor (FGF) 2 did not overcome this deficiency. Furthermore, AIB1/SRC-3(+/-) and (-/-) mice showed similarly delayed healing of full-thickness excisional skin wounds, indicating that both alleles were required for proper tissue repair. Analysis of this defective wound healing showed reduced recruitment of inflammatory cells and macrophages, cytokine induction, and metalloprotease activity. Skin grafts from animals with different AIB1 genotypes and subsequent wounding of the grafts revealed that the defective healing was attributable to local factors and not to defective bone marrow responses. Indeed, wounds in AIB1(+/-) mice showed reduced expression of FGF10, FGFBP3, FGFR1, FGFR2b, and FGFR3, major local drivers of angiogenesis. We conclude that AIB1/SRC-3 modulates stromal cell responses via cross-talk with the FGF signaling pathway.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007797 Laminin Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Merosin,Glycoprotein GP-2,Laminin M,Laminin M Chain,Chain, Laminin M,Glycoprotein GP 2,M Chain, Laminin
D008297 Male Males
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005346 Fibroblast Growth Factors A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family. DNA Synthesis Factor,Fibroblast Growth Factor,Fibroblast Growth Regulatory Factor,Growth Factor, Fibroblast,Growth Factors, Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Maram Al-Otaiby, and Elena Tassi, and Marcel O Schmidt, and Chris D Chien, and Tabari Baker, and Armando Ganoza Salas, and Jianming Xu, and Mary Furlong, and Richard Schlegel, and Anna T Riegel, and Anton Wellstein
September 2004, Clinical cancer research : an official journal of the American Association for Cancer Research,
Maram Al-Otaiby, and Elena Tassi, and Marcel O Schmidt, and Chris D Chien, and Tabari Baker, and Armando Ganoza Salas, and Jianming Xu, and Mary Furlong, and Richard Schlegel, and Anna T Riegel, and Anton Wellstein
December 2002, The Journal of steroid biochemistry and molecular biology,
Maram Al-Otaiby, and Elena Tassi, and Marcel O Schmidt, and Chris D Chien, and Tabari Baker, and Armando Ganoza Salas, and Jianming Xu, and Mary Furlong, and Richard Schlegel, and Anna T Riegel, and Anton Wellstein
April 2006, Acta pharmacologica Sinica,
Maram Al-Otaiby, and Elena Tassi, and Marcel O Schmidt, and Chris D Chien, and Tabari Baker, and Armando Ganoza Salas, and Jianming Xu, and Mary Furlong, and Richard Schlegel, and Anna T Riegel, and Anton Wellstein
February 2021, Scientific reports,
Maram Al-Otaiby, and Elena Tassi, and Marcel O Schmidt, and Chris D Chien, and Tabari Baker, and Armando Ganoza Salas, and Jianming Xu, and Mary Furlong, and Richard Schlegel, and Anna T Riegel, and Anton Wellstein
March 2003, Journal of the National Cancer Institute,
Maram Al-Otaiby, and Elena Tassi, and Marcel O Schmidt, and Chris D Chien, and Tabari Baker, and Armando Ganoza Salas, and Jianming Xu, and Mary Furlong, and Richard Schlegel, and Anna T Riegel, and Anton Wellstein
November 2005, Molecular and cellular biology,
Maram Al-Otaiby, and Elena Tassi, and Marcel O Schmidt, and Chris D Chien, and Tabari Baker, and Armando Ganoza Salas, and Jianming Xu, and Mary Furlong, and Richard Schlegel, and Anna T Riegel, and Anton Wellstein
January 2011, International journal of biological sciences,
Maram Al-Otaiby, and Elena Tassi, and Marcel O Schmidt, and Chris D Chien, and Tabari Baker, and Armando Ganoza Salas, and Jianming Xu, and Mary Furlong, and Richard Schlegel, and Anna T Riegel, and Anton Wellstein
November 2008, Molecular and cellular biology,
Maram Al-Otaiby, and Elena Tassi, and Marcel O Schmidt, and Chris D Chien, and Tabari Baker, and Armando Ganoza Salas, and Jianming Xu, and Mary Furlong, and Richard Schlegel, and Anna T Riegel, and Anton Wellstein
July 2011, The Journal of biological chemistry,
Maram Al-Otaiby, and Elena Tassi, and Marcel O Schmidt, and Chris D Chien, and Tabari Baker, and Armando Ganoza Salas, and Jianming Xu, and Mary Furlong, and Richard Schlegel, and Anna T Riegel, and Anton Wellstein
November 2003, Molecular and cellular biology,
Copied contents to your clipboard!